| 基因名 | 疾病 | 靶向药 | 化疗药 | 基因突变 | 临床解释 |
|---|---|---|---|---|---|
| SIPA1L2 | 0 | 0 | |||
| SIPA1 | 0 | 0 | |||
| SIN3A | 0 | 0 | |||
| SIMC1 | 0 | 0 | |||
| SIK1 | 0 | 0 | |||
| SI | 0 | 0 | |||
| SHROOM3 | 0 | 0 | |||
| SHQ1 | 0 | 0 | |||
| SHPRH | 0 | 0 | |||
| SHOC2 | 0 | 0 | |||
| SHMT1 | 0 | 0 | |||
| SHH | 0 | 0 | |||
| SHBG | 0 | 0 | |||
| SH3PXD2A | 0 | 0 | |||
| SH2D2A | 0 | 0 | |||
| SH2D1A | 0 | 0 | |||
| SH2B3 | 结直肠癌 | 1 | 1 | ||
| SGK1 | 乳腺癌 | 阿培利司,SGK1-Inh, | 1 | 3 | |
| SGCZ | 0 | 0 | |||
| SFXN4 | 0 | 0 | |||
| SFPQ | 0 | 0 | |||
| SF3B1 | 乳腺癌,慢性淋巴细胞白血病,骨髓增生异常综合征 | Spliceostatin A, | 3 | 9 | |
| SF3A3 | 0 | 0 | |||
| SF3A1 | 0 | 0 | |||
| SF1 | 0 | 0 | |||
| SETMAR | 0 | 0 | |||
| SETDB1 | 0 | 0 | |||
| SETD2 | 0 | 0 | |||
| SETBP1 | 慢性粒细胞白血病,少年粒细胞白血病 | 3 | 3 | ||
| SESN3 | 0 | 0 | |||
| SESN2 | 0 | 0 | |||
| SESN1 | 0 | 0 | |||
| SERPINB4 | 0 | 0 | |||
| SERPINB3 | 0 | 0 | |||
| SERPINA7 | 0 | 0 | |||
| SERP2 | 0 | 0 | |||
| Sept9 | 0 | 0 | |||
| Sept14 | 0 | 0 | |||
| SEMA6A | 0 | 0 | |||
| SEMA3E | 0 | 0 | |||
| SEMA3C | 0 | 0 | |||
| SEMA3A | 0 | 0 | |||
| SEL1L3 | 0 | 0 | |||
| SEC31A | 0 | 0 | |||
| SDHD | 0 | 0 | |||
| SDHC | 0 | 0 | |||
| SDHB | 副神经节瘤 | 1 | 1 | ||
| SDHAF2 | 0 | 0 | |||
| SDHA | 0 | 0 | |||
| SDCCAG8 | 0 | 0 | |||
| SDC4 | 0 | 0 | |||
| SCUBE2 | 0 | 0 | |||
| SCN8A | 肺腺癌 | 派姆单抗（帕博利珠单抗）, | 1 | 1 | |
| SCG5 | 0 | 0 | |||
| SBNO2 | 0 | 0 | |||
| SBDS | 0 | 0 | |||
| SATB2 | 0 | 0 | |||
| SASH1 | 0 | 0 | |||
| SAMD9 | 0 | 0 | |||
| SALL1 | 0 | 0 | |||
| RYR3 | 0 | 0 | |||
| RYR2 | 0 | 0 | |||
| RYR1 | 0 | 0 | |||
| RYBP | 0 | 0 | |||
| RXRG | 0 | 0 | |||
| RXRB | 0 | 0 | |||
| RXRA | 0 | 0 | |||
| RUNX3 | 0 | 0 | |||
| RUNX2 | 0 | 0 | |||
| RUNX1T1 | 0 | 0 | |||
| RUNX1 | 急性淋巴细胞性白血病,急性髓性白血病,骨髓增生异常综合征 | 阿糖胞苷, | 7 | 13 | |
| RUFY4 | 0 | 0 | |||
| RTEL1 | 0 | 0 | |||
| RSPO3 | 0 | 0 | |||
| RSPO2 | 0 | 0 | |||
| RSF1 | 乳腺癌 | 他莫昔芬, | 1 | 1 | |
| RRP1B | 0 | 0 | |||
| RRM2 | 胰腺癌 | 吉西他滨, | 1 | 1 | |
| RRM1 | 非小细胞肺癌,胰腺癌 | Cisplatine,PLATINUM, | 顺铂,多西他赛,吉西他滨,吉西他滨,顺铂,紫杉醇,长春瑞滨, | 2 | 9 |
| RRAS2 | 0 | 0 | |||
| RRAS | 0 | 0 | |||
| RRAGC | 0 | 0 | |||
| RPTOR | 0 | 0 | |||
| RPS7 | 0 | 0 | |||
| RPS6KB2 | 0 | 0 | |||
| RPS6KB1 | 0 | 0 | |||
| RPS6KA4 | 0 | 0 | |||
| RPS6KA3 | 0 | 0 | |||
| RPS6KA1 | 0 | 0 | |||
| RPS6 | 胃腺癌 | 依维莫司, | 1 | 1 | |
| RPS29 | 0 | 0 | |||
| RPS26 | 0 | 0 | |||
| RPS24 | 0 | 0 | |||
| RPS19 | 0 | 0 | |||
| RPS17 | 0 | 0 | |||
| RPS14 | 0 | 0 | |||
| RPS10 | 0 | 0 | |||
| RPP30 | 0 | 0 | |||
| RPL5 | 0 | 0 | |||
| RPL35A | 0 | 0 | |||
| RPL22 | 0 | 0 | |||
| RPL11 | 0 | 0 | |||
| RPGR | 0 | 0 | |||
| RPA4 | 0 | 0 | |||
| RPA1 | 0 | 0 | |||
| RP1L1 | 0 | 0 | |||
| ROS1 | 支气管肺泡腺癌,癌,大肠癌,多形胶质母细胞瘤,炎性肌成纤维细胞瘤,肺腺癌,非小细胞肺癌 | AZD3463,布加替尼,卡博替尼,色瑞替尼，塞瑞替尼,克唑替尼,恩曲替尼,Foretinib,吉非替尼,劳拉替尼,TAE684, | 12 | 31 | |
| ROCK2 | 0 | 0 | |||
| ROCK1 | 0 | 0 | |||
| ROBO4 | 癌症 | Antiangiogenic Therapy, | 1 | 1 | |
| ROBO3 | 0 | 0 | |||
| ROBO2 | 0 | 0 | |||
| ROBO1 | 0 | 0 | |||
| RNF43 | 0 | 0 | |||
| RNF213 | 0 | 0 | |||
| RNF19A | 0 | 0 | |||
| RNASEL | 0 | 0 | |||
| RMI2 | 0 | 0 | |||
| RIT1 | 子宫内膜癌,肺腺癌 | Pictilisib,司美替尼, | 2 | 2 | |
| RIPK4 | 0 | 0 | |||
| RIPK2 | 0 | 0 | |||
| RINT1 | 0 | 0 | |||
| RICTOR | 胃腺癌,肺腺癌,小细胞肺癌 | AZD2014,AZD8055,CC-223,INK128,Sapanisertib, | 1 | 3 | |
| RIC1 | 0 | 0 | |||
| RHPN1 | 0 | 0 | |||
| RHOT1 | 0 | 0 | |||
| RHOH | 0 | 0 | |||
| RHOA | 胃癌 | 1 | 1 | ||
| RHEB | 肾癌 | 西罗莫司, | 1 | 1 | |
| RHBDF2 | 0 | 0 | |||
| RGS3 | 0 | 0 | |||
| RGPD3 | 0 | 0 | |||
| RFC4 | 0 | 0 | |||
| RFC1 | 0 | 0 | |||
| REV3L | 0 | 0 | |||
| REV1 | 0 | 0 | |||
| RET | 乳腺癌,癌症,雌激素受体阴性乳腺癌,胃肠道间质瘤,肺腺癌,肺癌,非小细胞肺癌,乳头状腺癌,乳头状甲状腺癌,甲状腺癌,甲状腺髓样癌 | 阿来替尼，艾乐替尼,阿昔替尼,AZD1480,卡博替尼,依维莫司,INK128,仑伐替尼 乐伐替尼,塞尔帕替尼,尼达尼布,NVP-AST487,帕纳替尼/普纳替尼/波纳替尼,瑞戈非尼,索拉非尼,舒尼替尼,凡德他尼, | 莫特塞尼, | 13 | 36 |
| RELN | 0 | 0 | |||
| RELA | 0 | 0 | |||
| REL | 弥漫性大B细胞淋巴瘤 | 1 | 1 | ||
| REG3A | 0 | 0 | |||
| REEP5 | 0 | 0 | |||
| RECQL4 | 0 | 0 | |||
| RECQL | 0 | 0 | |||
| RBM27 | 0 | 0 | |||
| RBM10 | 0 | 0 | |||
| RBL1 | 0 | 0 | |||
| RBI | 0 | 0 | |||
| RBBP8 | 0 | 0 | |||
| RB1 | 乳腺癌,雌激素受体阳性乳腺癌,多形胶质母细胞瘤,非小细胞肺癌,小细胞肺癌,胰腺腺癌,膀胱癌 | 阿培利司,Chemotherapy,丝裂霉素C,哌柏西利,帕博西尼,帕博西林,瑞博西尼, | 氟尿嘧啶,多柔比星,吉西他滨, | 7 | 9 |
| RASSF8 | 0 | 0 | |||
| RASSF1 | 0 | 0 | |||
| RASGRP1 | 0 | 0 | |||
| RASGEF1A | 0 | 0 | |||
| RASA1 | 非小细胞肺癌 | 曲美替尼, | 1 | 1 | |
| RARG | 0 | 0 | |||
| RARB | 0 | 0 | |||
| RARA | 0 | 0 | |||
| RANBP2 | 0 | 0 | |||
| RAI14 | 0 | 0 | |||
| RAF1 | 黑色素瘤,皮肤黑色素瘤 | 索拉非尼,维莫非尼, | 卡铂,紫杉醇, | 2 | 2 |
| RAD54L | 0 | 0 | |||
| RAD54B | 0 | 0 | |||
| RAD52 | 0 | 0 | |||
| RAD51D | 乳腺癌 | 1 | 1 | ||
| RAD51C | 0 | 0 | |||
| RAD51B | 0 | 0 | |||
| RAD51 | 0 | 0 | |||
| RAD50 | 输尿管小细胞癌 | AZD7762, | 伊立替康, | 1 | 1 |
| RAD23B | 肉瘤 | 伏立诺他, | 1 | 1 | |
| RAD21 | 0 | 0 | |||
| RAC3 | 0 | 0 | |||
| RAC2 | 0 | 0 | |||
| RAC1 | 黑色素瘤 | 达拉非尼,维莫非尼, | 1 | 1 | |
| RABGAP1L | 0 | 0 | |||
| RAB35 | 0 | 0 | |||
| QKI | 0 | 0 | |||
| PXDNL | 肺腺癌 | 派姆单抗（帕博利珠单抗）, | 1 | 1 | |
| PURA | 0 | 0 | |||
| PTTG1 | 脑膜瘤 | 1 | 1 | ||
| PTPRZ1 | 0 | 0 | |||
| PTPRU | 0 | 0 | |||
| PTPRT | 头颈部鳞状细胞癌 | JSI-124,Stattic, | 1 | 1 | |
| PTPRS | 0 | 0 | |||
| PTPRO | 0 | 0 | |||
| PTPRK | 0 | 0 | |||
| PTPRJ | 0 | 0 | |||
| PTPRF | 非小细胞肺癌 | Erlotinib Hydrochloride, | 1 | 2 | |
| PTPRD | 骨尤文氏肉瘤,头颈癌 | 西妥木单抗,JSI-124,R1507, | 2 | 2 | |
| PTPRB | 血管肉瘤 | 舒尼替尼, | 1 | 1 | |
| PTPN6 | 肝细胞癌 | 1 | 1 | ||
| PTPN22 | 0 | 0 | |||
| PTPN2 | 0 | 0 | |||
| PTPN13 | 0 | 0 | |||
| PTPN12 | 三受体阴性乳腺癌 | 克唑替尼,舒尼替尼, | 1 | 1 | |
| PTPN11 | 少年骨髓单核细胞白血病,喉癌,毛细胞星形细胞瘤 | 3 | 3 | ||
| PTP4A3 | 结直肠癌 | 西妥昔单抗, | 1 | 1 | |
| PTP4A1 | 0 | 0 | |||
| PTK6 | 0 | 0 | |||
| PTK2B | 小儿B细胞急性淋巴细胞白血病 | 2 | 2 | ||
| PTK2 | 0 | 0 | |||
| PTGS2 | 结直肠癌 | 阿司匹林, | 1 | 1 | |
| PTGS1 | 0 | 0 | |||
| PTGIS | 0 | 0 | |||
| PTEN | 膀胱癌,乳腺癌,癌症,结直肠癌,子宫内膜癌,子宫内膜增生,胃腺癌,多形胶质母细胞瘤,头颈癌,头颈鳞状细胞癌,Her2受体阳性乳腺癌,黑色素瘤,卵巢癌,胰腺癌,前列腺癌腺癌,前列腺癌,pten错构瘤肿瘤综合征,皮肤黑色素瘤,实体瘤,胃癌,甲状腺癌 | Tanespimycin,Capivasertib,AZD8186,Buparlisib,阿培利司,西妥昔单抗,Chemotherapy,达可替尼,EGFR Inhibitor,恩扎鲁胺,厄洛替尼,依维莫司,氟维司群,吉非替尼,Uprosertib,Ipatasertib,拉帕替尼,LY294002,MK-2206,MTOR Inhibitors,帕尼单抗,PD184352,Perifosine,Pictilisib,Torkinib,Ridaforolimus,Taselisib,西罗莫司,曲妥珠单抗,维莫非尼, | 卡铂,顺铂,多西他赛,紫杉醇, | 8 | 53 |
| PTCH2 | 0 | 0 | |||
| PTCH1 | 基底细胞癌,脑髓母细胞瘤,癌,髓母细胞瘤 | 索尼德吉,维莫德吉, | 7 | 8 | |
| PSMD4 | 乳腺癌,结直肠癌 | 卡非佐米,他拉唑帕尼, | 2 | 2 | |
| PSMB8 | 胃腺癌 | 1 | 1 | ||
| PSMB5 | 0 | 0 | |||
| PSMB2 | 0 | 0 | |||
| PSMB1 | 0 | 0 | |||
| PSIP1 | 0 | 0 | |||
| PSG2 | 0 | 0 | |||
| PRX | 0 | 0 | |||
| PRSS8 | 0 | 0 | |||
| PRSS3 | 0 | 0 | |||
| PRSS1 | 0 | 0 | |||
| PRRX1 | 0 | 0 | |||
| PRRT2 | 0 | 0 | |||
| PRPF40B | 0 | 0 | |||
| PRPF39 | 0 | 0 | |||
| PROM1 | 肝细胞癌 | 索拉非尼, | 1 | 1 | |
| PROKR2 | 0 | 0 | |||
| PRKN | 0 | 0 | |||
| PRKDC | 0 | 0 | |||
| PRKD1 | 0 | 0 | |||
| PRKCI | 0 | 0 | |||
| PRKCG | 0 | 0 | |||
| PRKCE | 0 | 0 | |||
| PRKCB | 成人T细胞白血病 | 1 | 1 | ||
| PRKCA | 0 | 0 | |||
| PRKAR1A | 0 | 0 | |||
| PRKACG | 0 | 0 | |||
| PRKACB | 0 | 0 | |||
| PRKACA | 肝细胞纤维板层癌,肝细胞混合纤维板层癌 | 1 | 4 | ||
| PRKAA2 | 癌症 | ACLY SiRNA, | 1 | 1 | |
| PRKAA1 | 0 | 0 | |||
| PRIM2 | 0 | 0 | |||
| PRF1 | 0 | 0 | |||
| PREX2 | 黑色素瘤 | 维莫非尼, | 1 | 1 | |
| PRDM16 | 0 | 0 | |||
| PRDM14 | 0 | 0 | |||
| PRDM1 | 弥漫性大B细胞淋巴瘤 | 1 | 2 | ||
| PRCC | 0 | 0 | |||
| PRAM1 | 0 | 0 | |||
| PPP6C | 0 | 0 | |||
| PPP4R2 | 0 | 0 | |||
| PPP2R5B | 0 | 0 | |||
| PPP2R2A | 0 | 0 | |||
| PPP2R1A | 0 | 0 | |||
| PPP1R17 | 0 | 0 | |||
| PPP1R15A | 结直肠癌 | 贝伐单抗,FOLFIRI Regimen, | 1 | 1 | |
| PPM1D | 0 | 0 | |||
| PPHLN1 | 0 | 0 | |||
| PPARG | 0 | 0 | |||
| PPARD | 0 | 0 | |||
| POU5F1 | 结肠癌 | 奥沙利铂, | 1 | 1 | |
| POU2AF1 | 0 | 0 | |||
| POTEG | 0 | 0 | |||
| POT1 | 慢性淋巴细胞白血病 | 1 | 1 | ||
| POM121L12 | 0 | 0 | |||
| POM121 | 0 | 0 | |||
| POLR2B | 0 | 0 | |||
| POLQ | 0 | 0 | |||
| POLN | 0 | 0 | |||
| POLM | 0 | 0 | |||
| POLH | 0 | 0 | |||
| POLG | 0 | 0 | |||
| POLE4 | 肺腺癌 | 派姆单抗（帕博利珠单抗）, | 1 | 1 | |
| POLE | 结直肠癌,子宫内膜癌,多形性胶质母细胞瘤 | 派姆单抗（帕博利珠单抗）, | 4 | 5 | |
| POLDIP2 | 0 | 0 | |||
| POLD3 | 0 | 0 | |||
| POLD1 | 肺腺癌,非小细胞肺癌 | 派姆单抗（帕博利珠单抗）, | 3 | 3 | |
| PNRC1 | 0 | 0 | |||
| PNPLA3 | 0 | 0 | |||
| PNO1 | 0 | 0 | |||
| PMS2 | 多形性胶质母细胞瘤,林奇综合征 | 纳武单抗（纳武利尤单抗）, | 2 | 2 | |
| PMS1 | 0 | 0 | |||
| PML | 急性早幼粒细胞白血病 | All-trans Retinoic Acid, | 三氧化二砷, | 4 | 7 |
| PMAIP1 | 0 | 0 | |||
| PLXNB2 | 0 | 0 | |||
| PLXNA1 | 0 | 0 | |||
| PLPPR4 | 0 | 0 | |||
| PLK2 | 0 | 0 | |||
| PLK1 | 0 | 0 | |||
| PLEKHH2 | 0 | 0 | |||
| PLEKHA1 | 0 | 0 | |||
| PLCG2 | 慢性淋巴细胞白血病 | 1 | 1 | ||
| PLCG1 | 0 | 0 | |||
| PLCB1 | 0 | 0 | |||
| PLAG1 | 0 | 0 | |||
| PLAC8 | 0 | 0 | |||
| PLA2G1B | 0 | 0 | |||
| PKHD1 | 0 | 0 | |||
| PKD2 | 0 | 0 | |||
| PKD1L2 | 0 | 0 | |||
| PIP5K1A | 0 | 0 | |||
| PIM1 | 非小细胞肺癌 | 1 | 1 | ||
| PIK3R3 | 0 | 0 | |||
| PIK3R2 | 黑色素瘤 | 维莫非尼, | 2 | 2 | |
| PIK3R1 | 乳腺癌,多形性胶质母细胞瘤 | Buparlisib,Torkinib, | 1 | 2 | |
| PIK3CG | 0 | 0 | |||
| PIK3CD | 0 | 0 | |||
| PIK3CB | 0 | 0 | |||
| PIK3CA | 乳腺癌,癌症,宫颈癌,结直肠癌,子宫内膜癌,上皮性卵巢癌,雌激素受体阳性乳腺癌,胃腺癌,多形性胶质母细胞瘤,头颈癌,头颈鳞状细胞癌,HER2受体阳性乳腺癌,侵袭性管状乳腺癌,lunG腺癌,非小细胞肺癌,黑色素瘤,默克尔细胞癌,胃癌,甲状腺癌 | Tanespimycin,Ado-trastuzumab,阿法替尼,阿培利司,Anti-EGFR Monoclonal Antibody,Apitolisib,阿司匹林,Capivasertib,贝伐单抗,Dactolisib,Buparlisib,卡博替尼,Celecoxib,西妥昔单抗,CH5132799,厄洛替尼,依维莫司,氟维司群,吉非替尼,布洛芬,艾代拉里斯,拉帕替尼,MK-2206,Dactolisib,哌柏西利,帕博西尼,帕博西林,帕尼单抗,Perifosine,PI103,PI3K Inhibitor,Pictilisib,Torkinib,Radiation,西罗莫司,瑞戈非尼,瑞博西尼,Ridaforolimus,Taselisib,曲美替尼,曲妥珠单抗,维莫非尼, | 氟尿嘧啶,顺铂,环磷酰胺,多柔比星,表柔比星,伊立替康,奥沙利铂,紫杉醇,舒林酸,他莫昔芬, | 40 | 265 |
| PIK3C3 | 0 | 0 | |||
| PIK3C2G | 0 | 0 | |||
| PIK3C2B | 0 | 0 | |||
| PIK3C2A | 0 | 0 | |||
| PIGF | 0 | 0 | |||
| PIBF1 | 0 | 0 | |||
| PHOX2B | 0 | 0 | |||
| PHLPP2 | 0 | 0 | |||
| PHF7 | 0 | 0 | |||
| PHF6 | 0 | 0 | |||
| PHF20L1 | 0 | 0 | |||
| PHF1 | 0 | 0 | |||
| PH0X2B | 0 | 0 | |||
| PGR | 乳腺癌 | 依西美坦, | 他莫昔芬, | 1 | 4 |
| PGBD1 | 0 | 0 | |||
| PER1 | 0 | 0 | |||
| PEG3 | 0 | 0 | |||
| PDZRN3 | 0 | 0 | |||
| PDYN | 0 | 0 | |||
| PDPN | 0 | 0 | |||
| PDPK1 | 0 | 0 | |||
| PDK1 | 0 | 0 | |||
| PDILT | 0 | 0 | |||
| PDHA2 | 0 | 0 | |||
| PDGFRB | 急性淋巴细胞白血病,成人B淋巴细胞白血病,慢性骨髓单核细胞白血病,慢性骨髓增生性疾病,血液学癌症,小儿B细胞急性淋巴细胞白血病,小儿B细胞淋巴细胞白血病 | 巴非替尼,CHZ868,达沙替尼,伊马替尼,尼洛替尼,帕纳替尼/普纳替尼/波纳替尼,Rebastinib, | 4 | 11 | |
| PDGFRA | 癌症,慢性骨髓单核细胞白血病,胃肠道间质瘤,非小细胞肺癌,黑色素瘤,骨髓和淋巴肿瘤伴嗜酸性粒细胞增多和pdgfra,pdgfrb和fgfr1异常 | Crenolanib,达沙替尼,伊马替尼,Imatinib Mesylate,帕纳替尼/普纳替尼/波纳替尼,舒尼替尼, | 21 | 45 | |
| PDGFB | 小儿B淋巴细胞白血病 | 达沙替尼,伊马替尼, | 1 | 1 | |
| PDE6C | 0 | 0 | |||
| PDE4DIP | 0 | 0 | |||
| PDE4D | 0 | 0 | |||
| PDE3A | 0 | 0 | |||
| PDE1C | 0 | 0 | |||
| PDE11A | 0 | 0 | |||
| PDCD4 | 肺癌 | 紫杉醇, | 1 | 1 | |
| PDCD1LG2 | 头颈癌 | 派姆单抗（帕博利珠单抗）, | 1 | 1 | |
| PDCD11 | 0 | 0 | |||
| PDCD1 | 0 | 0 | |||
| PCSK7 | 0 | 0 | |||
| PCSK6 | 0 | 0 | |||
| PCLO | 0 | 0 | |||
| PCK1 | 0 | 0 | |||
| PCDH9 | 0 | 0 | |||
| PCDH18 | 0 | 0 | |||
| PCDH17 | 0 | 0 | |||
| PCDH10 | 0 | 0 | |||
| PCBP1 | 0 | 0 | |||
| PC | 0 | 0 | |||
| PBX1 | 0 | 0 | |||
| PBRM1 | 透明细胞肾细胞癌,肾细胞癌 | 阿特朱单抗，阿替利珠单抗,阿维单抗 巴文西亚,度伐利尤单抗，德瓦鲁单抗,CTLA-4 Inhibitor,依维莫司,伊匹单抗,PD-L1 Antibody,派姆单抗（帕博利珠单抗）,纳武单抗（纳武利尤单抗）, | 2 | 5 | |
| PBLD | 肝细胞癌 | 1 | 1 | ||
| PBK | 胃腺癌,非小细胞肺癌 | 吉非替尼, | 2 | 2 | |
| PAX8 | 女性生殖器官癌 | 2 | 2 | ||
| PAX7 | 0 | 0 | |||
| PAX5 | 小儿B淋巴细胞白血病 | 1 | 2 | ||
| PAX3 | 0 | 0 | |||
| PASK | 0 | 0 | |||
| PARP4 | 0 | 0 | |||
| PARP3 | 0 | 0 | |||
| PARP2 | 0 | 0 | |||
| PARP1 | 周围神经鞘恶性肿瘤 | 奥拉帕利, | 1 | 1 | |
| PARK2 | 0 | 0 | |||
| PAQR8 | 0 | 0 | |||
| PAPPA2 | 肺腺癌 | 派姆单抗（帕博利珠单抗）, | 1 | 1 | |
| PAPOLG | 0 | 0 | |||
| PALLD | 0 | 0 | |||
| PALB2 | 乳腺癌,胰腺癌,前列腺癌 | 丝裂霉素C,奥拉帕利, | 2 | 3 | |
| Pak7 | 0 | 0 | |||
| PAK6 | 0 | 0 | |||
| PAK5 | 0 | 0 | |||
| PAK3 | 0 | 0 | |||
| PAK1 | 0 | 0 | |||
| PAG1 | 0 | 0 | |||
| PABPC3 | 0 | 0 | |||
| PABPC1 | 0 | 0 | |||
| P4HB | 0 | 0 | |||
| P2RY8 | 0 | 0 | |||
| OTOS | 0 | 0 | |||
| OSBPL9 | 0 | 0 | |||
| OR6F1 | 0 | 0 | |||
| OR5L2 | 0 | 0 | |||
| OR4C6 | 0 | 0 | |||
| OR4A15 | 0 | 0 | |||
| OR2T4 | 0 | 0 | |||
| OR11G2 | 0 | 0 | |||
| OPRM1 | 0 | 0 | |||
| OPCML | 0 | 0 | |||
| OMD | 0 | 0 | |||
| OGDH | 0 | 0 | |||
| OBSL1 | 0 | 0 | |||
| OBSCN | 0 | 0 | |||
| NYAP2 | 0 | 0 | |||
| NUTM2A | 0 | 0 | |||
| NUTM1 | 0 | 0 | |||
| NUP98 | 急性髓性白血病 | 1 | 1 |
Copyright © 2020 基因医生
京ICP备13051264号-65 
京公网安备
11010802036025号